KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Times Interest Earned (2023 - 2025)

Historic Times Interest Earned for Travere Therapeutics (TVTX) over the last 9 years, with Q3 2025 value amounting to $8.9.

  • Travere Therapeutics' Times Interest Earned rose 14440.15% to $8.9 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.03, marking a year-over-year increase of 7477.74%. This contributed to the annual value of -$28.91 for FY2024, which is 1557.09% up from last year.
  • Travere Therapeutics' Times Interest Earned amounted to $8.9 in Q3 2025, which was up 14440.15% from -$4.44 recorded in Q2 2025.
  • Travere Therapeutics' Times Interest Earned's 5-year high stood at $8.9 during Q3 2025, with a 5-year trough of -$49.73 in Q1 2024.
  • Moreover, its 3-year median value for Times Interest Earned was -$22.94 (2024), whereas its average is -$22.87.
  • As far as peak fluctuations go, Travere Therapeutics' Times Interest Earned surged by 3386.91% in 2024, and later surged by 14440.15% in 2025.
  • Travere Therapeutics' Times Interest Earned (Quarter) stood at -$33.4 in 2023, then surged by 35.06% to -$21.69 in 2024, then surged by 141.05% to $8.9 in 2025.
  • Its last three reported values are $8.9 in Q3 2025, -$4.44 for Q2 2025, and -$14.72 during Q1 2025.